Logo image of OAS

Oasis Petroleum Inc (OAS) Stock Fundamental Analysis

USA - NASDAQ:OAS - US6742152076 - Common Stock

109.3
-12.35 (-10.15%)
Last: 7/1/2022, 8:00:02 PM
109.3
0 (0%)
After Hours: 7/1/2022, 8:00:02 PM
Fundamental Rating

4

Overall OAS gets a fundamental rating of 4 out of 10. We evaluated OAS against 210 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of OAS have multiple concerns. OAS is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year OAS was profitable.
OAS Yearly Net Income VS EBIT VS OCF VS FCFOAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -1B -2B -3B

1.2 Ratios

Industry RankSector Rank
ROA 30.95%
ROE 64.56%
ROIC 46.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OAS Yearly ROA, ROE, ROICOAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -100 -200 -300 -400

1.3 Margins

Industry RankSector Rank
OM 40.55%
PM (TTM) 30.74%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OAS Yearly Profit, Operating, Gross MarginsOAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OAS is creating value.
Compared to 1 year ago, OAS has more shares outstanding
The debt/assets ratio for OAS has been reduced compared to a year ago.
OAS Yearly Shares OutstandingOAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M
OAS Yearly Total Debt VS Total AssetsOAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

OAS has an Altman-Z score of 4.00. This indicates that OAS is financially healthy and has little risk of bankruptcy at the moment.
OAS has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 4
ROIC/WACC3.88
WACC11.86%
OAS Yearly LT Debt VS Equity VS FCFOAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B 2B 3B

2.3 Liquidity

OAS has a Current Ratio of 1.06. This is a normal value and indicates that OAS is financially healthy and should not expect problems in meeting its short term obligations.
OAS has a Quick Ratio of 1.03. This is a normal value and indicates that OAS is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.03
OAS Yearly Current Assets VS Current LiabilitesOAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

9

3. Growth

3.1 Past

OAS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 224.43%, which is quite impressive.
OAS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 81.92% yearly.
OAS shows a strong growth in Revenue. In the last year, the Revenue has grown by 188.08%.
Measured over the past years, OAS shows a quite strong growth in Revenue. The Revenue has been growing by 17.52% on average per year.
EPS 1Y (TTM)224.43%
EPS 3Y827.16%
EPS 5Y81.92%
EPS Q2Q%91.71%
Revenue 1Y (TTM)188.08%
Revenue growth 3Y-12.04%
Revenue growth 5Y17.52%
Sales Q2Q%83.68%

3.2 Future

The Earnings Per Share is expected to grow by 35.89% on average over the next years. This is a very strong growth
Based on estimates for the next years, OAS will show a very strong growth in Revenue. The Revenue will grow by 34.05% on average per year.
EPS Next Y126.08%
EPS Next 2Y54.4%
EPS Next 3Y47.79%
EPS Next 5Y35.89%
Revenue Next Year117.63%
Revenue Next 2Y75.4%
Revenue Next 3Y44.79%
Revenue Next 5Y34.05%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OAS Yearly Revenue VS EstimatesOAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
OAS Yearly EPS VS EstimatesOAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 20 40 60

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

OAS is valuated cheaply with a Price/Earnings ratio of 5.49.
OAS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
With a Price/Forward Earnings ratio of 2.88, the valuation of OAS can be described as very cheap.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, OAS is valued rather cheaply.
Industry RankSector Rank
PE 5.49
Fwd PE 2.88
OAS Price Earnings VS Forward Price EarningsOAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.53
OAS Per share dataOAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

OAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OAS's earnings are expected to grow with 47.79% in the coming years.
PEG (NY)0.04
PEG (5Y)0.07
EPS Next 2Y54.4%
EPS Next 3Y47.79%

More info and screens

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.83%, OAS has a reasonable but not impressive dividend return.
In the last 3 months the price of OAS has falen by -27.08%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
OAS's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.83%

5.2 History

OAS does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
OAS Yearly Dividends per shareOAS Yearly Dividends per shareYearly Dividends per share 2021 2022 5 10 15 20

5.3 Sustainability

18.80% of the earnings are spent on dividend by OAS. This is a low number and sustainable payout ratio.
DP18.8%
EPS Next 2Y54.4%
EPS Next 3Y47.79%
OAS Yearly Income VS Free CF VS DividendOAS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 -1B -2B -3B
OAS Dividend Payout.OAS Dividend Payout, showing the Payout Ratio.OAS Dividend Payout.PayoutRetained Earnings

More info and screens

Oasis Petroleum Inc

NASDAQ:OAS (7/1/2022, 8:00:02 PM)

After market: 109.3 0 (0%)

109.3

-12.35 (-10.15%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-04 2022-05-04/amc
Earnings (Next)08-02 2022-08-02/amc
Inst Owners279.76%
Inst Owner Change0.23%
Ins Owners198.94%
Ins Owner Change0%
Market Cap2.15B
Analysts80
Price Target208.93 (91.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.83%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP18.8%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.49
Fwd PE 2.88
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB N/A
EV/EBITDA 1.53
EPS(TTM)19.92
EY18.23%
EPS(NY)38
Fwd EY34.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS154.27
BVpS73.47
TBVpSN/A
PEG (NY)0.04
PEG (5Y)0.07
Profitability
Industry RankSector Rank
ROA 30.95%
ROE 64.56%
ROCE N/A
ROIC 46.03%
ROICexc N/A
ROICexgc 46.03%
OM 40.55%
PM (TTM) 30.74%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 1.03
Altman-Z 4
F-Score8
WACC11.86%
ROIC/WACC3.88
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)224.43%
EPS 3Y827.16%
EPS 5Y81.92%
EPS Q2Q%91.71%
EPS Next Y126.08%
EPS Next 2Y54.4%
EPS Next 3Y47.79%
EPS Next 5Y35.89%
Revenue 1Y (TTM)188.08%
Revenue growth 3Y-12.04%
Revenue growth 5Y17.52%
Sales Q2Q%83.68%
Revenue Next Year117.63%
Revenue Next 2Y75.4%
Revenue Next 3Y44.79%
Revenue Next 5Y34.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A